| 发明名称 |
PHYTOCANNABINOIDS FOR USE IN THE TREATMENT OF INTESTINAL INFLAMMATORY DISEASES |
| 摘要 |
The present invention relates to one or more of the phytocannabinoids tetrahydrocannabivarin (THCV); cannabigerol (CBG); cannabichromene (CBC); and cannabidivarin (CBDV) for use in the treatment of intestinal inflammatory diseases. Preferably the intestinal inflammatory disease is either ulcerative colitis or Crohn's disease. |
| 申请公布号 |
US2014343136(A1) |
申请公布日期 |
2014.11.20 |
| 申请号 |
US201214359192 |
申请日期 |
2012.11.21 |
| 申请人 |
GW Pharma Limited |
发明人 |
Izzo Angelo Antonio;Borelli Francesca;Wright Stephen |
| 分类号 |
A61K31/352 |
主分类号 |
A61K31/352 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for curative treatment of intestinal inflammatory diseases comprising administering to a subject suffering from intestinal inflammatory disease a therapeutically effective amount of a phytocannabinoid consisting essentially of tetrahydrocannabivarin (THCV). |
| 地址 |
Salisbury GB |
